Gulf International Bank (Uk) LTD Alnylam Pharmaceuticals, Inc. Transaction History

Gulf International Bank (Uk) LTD

$3.96 Billion
Q4 2024

A detailed history of Gulf International Bank (Uk) LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 9,754 shares of ALNY stock, worth $2.58 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

9,754

Previous 9,853 1.0%

Holding current value

$2.58 Million

Previous $2.71 Million 15.28%

% of portfolio

0.06%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$232.27 - $300.43 $22,994 - $29,742	-99 Reduced 1.0%	9,754 $2.3 Million
Q3 2024 Oct 30, 2024	SELL	$233.81 - $287.01 $111,059 - $136,329	-475 Reduced 4.6%	9,853 $2.71 Million
Q4 2023 Jan 11, 2024	SELL	$151.41 - $196.57 $146,564 - $190,279	-968 Reduced 8.57%	10,328 $1.98 Million
Q3 2023 Oct 10, 2023	SELL	$170.77 - $211.65 $217,560 - $269,642	-1,274 Reduced 10.14%	11,296 $2 Million
Q2 2023 Aug 02, 2023	SELL	$185.01 - $212.05 $682,871 - $782,676	-3,691 Reduced 22.7%	12,570 $2.39 Million
Q1 2023 Apr 12, 2023	SELL	$182.66 - $235.53 $680,408 - $877,349	-3,725 Reduced 18.64%	16,261 $3.26 Million
Q4 2022 Feb 08, 2023	BUY	$185.53 - $241.31 $13,914 - $18,098	75 Added 0.38%	19,986 $4.75 Million
Q3 2022 Oct 07, 2022	SELL	$138.54 - $232.0 $27,015 - $45,240	-195 Reduced 0.97%	19,911 $3.99 Million
Q2 2022 Jul 19, 2022	BUY	$120.42 - $169.29 $23,481 - $33,011	195 Added 0.98%	20,106 $2.93 Million
Q4 2021 Jan 24, 2022	SELL	$159.56 - $209.29 $590,372 - $774,373	-3,700 Reduced 15.67%	19,911 $3.38 Million
Q2 2021 Aug 10, 2021	SELL	$128.63 - $176.89 $19,294 - $26,533	-150 Reduced 0.63%	23,611 $4 Million
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $329,758 - $456,794	-2,600 Reduced 9.86%	23,761 $3.35 Million
Q4 2020 Feb 12, 2021	SELL	$122.97 - $147.0 $359,072 - $429,240	-2,920 Reduced 9.97%	26,361 $3.43 Million
Q3 2019 Oct 08, 2019	BUY	$70.9 - $87.82 $659,370 - $816,725	9,300 Added 46.54%	29,281 $2.35 Million
Q1 2019 Apr 18, 2019	BUY	$72.76 - $93.45 $53,405 - $68,592	734 Added 3.81%	19,981 $1.87 Million
Q4 2018 Jan 08, 2019	SELL	$62.67 - $88.33 $620,433 - $874,467	-9,900 Reduced 33.97%	19,247 $1.4 Million
Q1 2018 May 09, 2018	SELL	$115.92 - $148.54 $81,491 - $104,423	-703 Reduced 2.36%	29,147 $3.47 Million
Q4 2017 Jan 17, 2018	BUY	$114.49 - $139.98 $3.42 Million - $4.18 Million	29,850	29,850 $3.79 Million

Others Institutions Holding ALNY

# of Institutions

686

Shares Held

110M

Call Options Held

1.23M

Put Options Held

1.19M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.

Account

Gulf International Bank (Uk) LTD Alnylam Pharmaceuticals, Inc. Transaction History